Follow the 株式会社レナサイエンス stock price and the full directors' dealings record of the company, a listed issuer based in Japan. Shares are quoted on JP JP, under the oversight of EDINET (Japan FSA). Operating in the Health Care sector, 株式会社レナサイエンス has recorded 7 public disclosures. Market capitalisation: €15.5bn. The latest transaction was disclosed on 26 May 2026 (Holding update). Among the most active insiders: Heights Capital Management, Inc.. The full history is openly available.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
7 of 7 declarations
株式会社レナサイエンス is a company focused on the health and pharmaceutical sector, providing innovative solutions for well-being. It is listed on the XTKS market.